These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction therapy: why, when, and which agent? Krischock L; Marks SD Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609 [TBL] [Abstract][Full Text] [Related]
6. Immunopharmacologic therapy in renal transplantation. Shoker AS Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362 [TBL] [Abstract][Full Text] [Related]
7. The new immunosuppressive era. Lo Monte AI; Ciancio G; Burke G; Roth D; Miller J Ann Ital Chir; 1999; 70(1):1-19. PubMed ID: 10367502 [TBL] [Abstract][Full Text] [Related]
8. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370 [TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressive treatment after kidney transplant: the frontier of chronic antibody-mediated rejection]. Biancone L; Lavacca A; Beltramo S; Ariaudo C; Gallo E; Segoloni GP G Ital Nefrol; 2012; 29(5):579-91. PubMed ID: 23117738 [TBL] [Abstract][Full Text] [Related]
10. Evidence for immunosuppression in lung transplantation. Hopkins PM; McNeil K Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppression for lung transplantation. Bhorade SM; Stern E Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530 [TBL] [Abstract][Full Text] [Related]
12. Finding the right time for weaning off immunosuppression in solid organ transplant recipients. Orlando G Expert Rev Clin Immunol; 2010 Nov; 6(6):879-92. PubMed ID: 20979553 [TBL] [Abstract][Full Text] [Related]
14. Strategies for minimizing immunosuppression in kidney transplantation. Kirk AD; Mannon RB; Swanson SJ; Hale DA Transpl Int; 2005 Jan; 18(1):2-14. PubMed ID: 15612977 [TBL] [Abstract][Full Text] [Related]
15. How can we measure immunologic tolerance in humans? Najafian N; Albin MJ; Newell KA J Am Soc Nephrol; 2006 Oct; 17(10):2652-63. PubMed ID: 16928808 [TBL] [Abstract][Full Text] [Related]
16. Future trends in organ transplant recipients--important issues for dermatologists. Zecher D; Steiger J Curr Probl Dermatol; 2012; 43():71-80. PubMed ID: 22377921 [TBL] [Abstract][Full Text] [Related]
17. Evolving immunosuppressive regimens for lung transplant recipients. Meyer NJ; Bhorade SM Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795 [TBL] [Abstract][Full Text] [Related]
18. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids. Cantarovich D J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885 [TBL] [Abstract][Full Text] [Related]
19. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091 [TBL] [Abstract][Full Text] [Related]
20. Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients. Geissler EK; Hutchinson JA Curr Opin Organ Transplant; 2013 Aug; 18(4):408-15. PubMed ID: 23838645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]